Ondansetron Orally Disintegrating Tablets
Responses closed . Full description on SAM.gov.
Overview
- Response deadline
- 3:00 PM EDT
- Posted
- April 8, 2026
- Notice type
- Solicitation
- NAICS
- 325412: Pharmaceutical Preparation Manufacturing
- Agency
- Department of WarDEFENSE LOGISTICS AGENCY
Notice details
- Office
- TROOP SUPPORT MEDICAL.DLA TROOP SUPPORT
- Last updated
- Oct 28, 2026
- First published
- Last updated on SAM.gov
Identifiers
- Solicitation number
- SPE2D2-25-R-0018
- Notice ID
- 5bdd0ce9e9f34d9f911b37c1f9e94bc0
Description
Amendment 0004 issued since this procurement is using the procedures of 41 U.S.C. 1901, as implemented by Class Deviation 2026-O0028 – Revolutionary Federal Acquisition Regulation (FAR) Overhaul Part 12, Defense FAR Supplement (DFARS) Part 212 and Revolutionary FAR Overhaul Part 12.201-1. See updated Ondansetron ODT Solicitation attached.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Contracting Officer
Primary Contact
Secondary Contact
Documents
Files (6)
- Download
Updated Ondansetron Solicitation - FAR Overhaul - 08.Apr.2026.pdf
1.4 MBAdded in Solicitation version 6Posted - Download
Amendment 0003 - Ondansetron ODT.pdf
107 KBAdded in Solicitation version 5Posted - Download
Amendment 0002 - Ondansetron ODT.pdf
11 KBAdded in Solicitation version 4Posted - Download
Schedule of Supplies - Ondansetron - Revised.pdf
118 KBAdded in Solicitation version 3Posted - Download
Amendment 0001 - Ondansetron ODT.pdf
12 KBAdded in Solicitation version 3Posted - Download
Ondansetron ODT Solicitation - SPE2D2-25-R-0018.pdf
1.3 MBAdded in Solicitation version 2Posted
Lifecycle
- 1Version 1Presolicitation
Ondansetron Orally Disintegrating Tablets
- 2Version 2Solicitation
Type changed from Presolicitation to Solicitation
Ondansetron Orally Disintegrating Tablets
- 3Version 3Solicitation
Ondansetron Orally Disintegrating Tablets
- 4Version 4Solicitation
Ondansetron Orally Disintegrating Tablets
- 5Version 5Solicitation
Ondansetron Orally Disintegrating Tablets
- 6Version 6SolicitationCurrent
Ondansetron Orally Disintegrating Tablets
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
SPE2D2-25-R-0018
Archive Date
Mar 30, 2027
Office Address
PHILADELPHIA, PA, 19111